CoChat

Menin inhibitor MI-3454 induces remission in MLL1-rearranged and NPM1-mutated models of leukemia

Open access
Klossowski, Szymon, Miao, Hongzhi, Kempinska, Katarzyna, Wu, Tao, Purohit, Trupta, Kim, EunGi, Linhares, Brian M., Chen, Dong, Jih, Gloria, Perkey, Eric, Huang, Huang, He, Miao, Wen, Bo, Wang, Yi, Yu, Ke, Lee, Stanley Chun-Wei, Danet-Desnoyers, Gwenn, Trotman, Winifred, Kandarpa, Malathi, Cotton, Anitria, Abdel-Wahab, Omar, Lei, Hongwei, Dou, Yali, Guzman, Monica, Peterson, Luke, Gruber, Tanja, Choi, Sarah, Sun, Duxin, Ren, Pingda, Li, Lian-Sheng, Liu, Yi, Burrows, Francis, Maillard, Ivan, Cierpicki, Tomasz, Grembecka, Jolanta · 2020 · Journal of Clinical Investigation
Cited by 246

The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.

Abstract

The protein-protein interaction between menin and mixed lineage leukemia 1 (MLL1) plays a critical role in acute leukemias with translocations of the MLL1 gene or with mutations in the nucleophosmin 1 (NPM1) gene. As a step toward clinical translation of menin-MLL1 inhibitors, we report development of MI-3454, a highly potent and orally bioavailable inhibitor of the menin-MLL1 interaction. MI-3454 profoundly inhibited proliferation and induced differentiation in acute leukemia cells and primary patient samples with MLL1 translocations or NPM1 mutations. When applied as a single agent, MI-3454 induced complete remission or regression of leukemia in mouse models of MLL1-rearranged or NPM1-mutated leukemia, including patient-derived xenograft models, through downregulation of key genes involved in leukemogenesis. We also identified MEIS1 as a potential pharmacodynamic biomarker of treatment response with MI-3454 in leukemia, and demonstrated that this compound is well tolerated and did not impair normal hematopoiesis in mice. Overall, this study demonstrates, for the first time to our knowledge, profound activity of the menin-MLL1 inhibitor as a single agent in clinically relevant PDX models of leukemia. These data provide a strong rationale for clinical translation of MI-3454 or its analogs for leukemia patients with MLL1 rearrangements or NPM1 mutations.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1172/jci129126

Cites

7 of 7 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 7 references

Cited by

See all 246

Metadata

Authors
Klossowski, S., Miao, H., Kempinska, K., Wu, T., Purohit, T., Kim, E., Linhares, B. M., Chen, D., Jih, G., Perkey, E., Huang, H., He, M., Wen, B., Wang, Y., Yu, K., Lee, S. C.-W., Danet-Desnoyers, G., Trotman, W., Kandarpa, M., Cotton, A., Abdel-Wahab, O., Lei, H., Dou, Y., Guzman, M., Peterson, L., Gruber, T., Choi, S., Sun, D., Ren, P., Li, L.-S., Liu, Y., Burrows, F., Maillard, I., Cierpicki, T., & Grembecka, J.
Venue
Journal of Clinical Investigation
Published
2020-01-21
Volume
130
Issue
2
Pages
981-997
ISSN
  • 0021-9738 (ISSN-L)
  • 1558-8238
OpenAlex
W4242135586
Cited by
246
References
7
FWCI
16.77
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Menin inhibitor MI-3454 induces remission in MLL1-rearranged and NPM1-mutated models of leukemia. https://app.cochat.ai/papers/10.1172/jci129126
The paper
Klossowski, S., Miao, H., Kempinska, K., Wu, T., Purohit, T., Kim, E., Linhares, B. M., Chen, D., Jih, G., Perkey, E., Huang, H., He, M., Wen, B., Wang, Y., Yu, K., Lee, S. C.-W., Danet-Desnoyers, G., Trotman, W., Kandarpa, M., . . . Grembecka, J. (2020). Menin inhibitor MI-3454 induces remission in MLL1-rearranged and NPM1-mutated models of leukemia. Journal of Clinical Investigation. https://doi.org/10.1172/jci129126

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.